Gmail users: to ensure you're always viewing the entire newsletter, check at the bottom of the email to see if the newsletter has been "clipped" and click "view entire message" if so.
|
|
|
Griswold Selected to Co-lead University "Think Big" Pathway to Integrate Humanity and Technology
|
Mark Griswold, PhD, professor of radiology at Case Western Reserve University (CWRU) School of Medicine, alongside Maggie Popkin, PhD associate professor of art history, has been selected to co-lead one of four university "pathways" as part of CWRU's
Think Big strategic plan. Dr. Griswold is a member of the Case Comprehensive Cancer Center's Cancer Imaging Program. He and other Pathway Leaders will act as advisors to Provost Vinson III and liaise with the the university community to better understand how everyone can engage with the plan.
|
|
Join Team Case CCC in VeloSano 2020!
|
The Case Comprehensive Cancer Center (Case CCC) is honored to make its sixth appearance in
VeloSano, a year-round fundraising initiative and "Bike to Cure" weekend to support lifesaving cancer research. Our continuing goal is to bring sustainable funding to cancer research by enlisting the passion and energy of thousands of people who wish to give back... including
YOU! We raised nearly $94,000 in 2019 and every dollar goes directly toward cancer research. In our six years of participation, more than $1,000,000 of VeloSano fundraising totals have come back to the Case CCC to award researchers as pilot funding for cancer research projects.
|
|
The Case CCC will provide complimentary registration fees and jerseys again this year. Contact team captains
Caroline El Sanadi or
Mary Wright for the registration fee waiver code to sign up! While registration is complimentary, all riders are responsible for meeting the minimum fundraising commitment associated with the
distance they ride. Fundraising can begin as soon as you register to ride and continues through October 1, 2020.
Registration is open now and information about volunteering for our cheer station and supporting our team through sponsorship will be available soon!
|
|
Tues, Feb 4
Cancer Impact Lecture
1p NE1-205
High Risk Germline Focus Group
5:15p NE5-218
|
|
Weds, Feb 5
Cancer Microbiome Focus Group
12p WRB 1-422D
|
|
Thurs, Feb 6
D
evelopmental Therapeutics Journal Club
9a NE6-218
Molecular Biology and Microbiology Seminar
1p SOM W203
|
|
Fri, Feb 7
Taussig Cancer Institute Grand Rounds
8a CA5-120
Cancer Center Seminar Series
Quintin Pan, PhD
12p WRB Auditorium
|
|
|
Mon, Feb 10
Shared Resources Directors Meeting
12p WRB 1-422D
Case CCC Junior Faculty Meeting
"IP & Technology Transfer"
1:30p WRB 1-422D
|
|
Tues, Feb 11
Cancer Impact Lecture
1p NE1-205
|
|
Weds, Feb 12
Breast Cancer Update
11:45a Embassy Suites Independence
Disparities SPORE Meeting
Natalie Joseph, MD and Fred Schumacher, PhD
5-7p WRB 2-136
|
|
Thurs, Feb 13
D
evelopmental Therapeutics Journal Club
9a NE6-218
Immuno-Oncology Seminar Series
Tyler Curiel, MD, MPH
11a NC1-202
Synthego CRISPR Seminar
11:30a WRB 2-136
Immunology Journal Club
12p WRB 5-136
Molecular Biology and Microbiology Seminar
1p SOM W203
|
|
Fri, Feb 14
Taussig Cancer Institute Grand Rounds
8a CA5-120
UH Seidman Cancer Center Grand Rounds
8a Wearn 137
Cancer Center Seminar Series
Jan Grimm, PhD
12p WRB Auditorium
|
|
|
|
Cancer Center Seminar Series
January 31, 12p
WRB Auditorium
Our weekly seminar series features
Lily Wang, PhD at noon today in the auditorium of the Wolstein Research Building.
(Note: an earlier version of this newsletter incorrectly identified today's speaker.)
Dr. Wang is associate staff, translational hematology and oncology research at the Cleveland Clinic Lerner Research Institute. Dr. Wang’s previous studies have identified a novel immune checkpoint protein that was named as V domain Immunoglobulin Suppression of T cell Activation (VISTA). Currently, her research group is committed to discovering novel receptors and signaling adapter proteins that interact with VISTA and mediate immunosuppression. These efforts will guide the effort in developing effective approaches that block the VISTA immune checkpoint pathway for cancer therapy.
She will present, "VISTA, the Next Generation Immune Checkpoint Target for Cancer Immunotherapy" on behalf of the Hematopoietic and Immune Cancer Biology Program.
|
|
|
|
Cancer Center Seminar Series
February 7, 12p
WRB Auditorium
Next week's cancer center seminar will be presented by
Quintin Pan, PhD on behalf of the Molecular Oncology Program.
Dr. Pan is Deputy Director for Research and the Dr. Lester E. Coleman, Jr. chair in Cancer Research and Therapeutics at University Hospitals Seidman Cancer Center. He is also a professor of otolaryngology at the Case Western Reserve University School of Medicine and Co-Leader of the Case CCC's Molecular Oncology Program. In addition to his administrative roles, he maintains a vibrant research program on novel target discovery and drug development in head and neck cancer.
He will present, "Novel Biomarker and Drug Discovery Platforms for HPV+ Head and Neck Cancer" at noon in the WRB Auditorium.
|
|
|
|
|
Bring the Power of CRISPR to Your Research
February 13, 11:30a-1p
WRB 2-136
Join Synthego to learn more about the easiest way to start using CRISPR in your research. See how your lab can use genome engineering to drive your research forward and accelerate discoveries.
Register for this seminar to learn how you can best utilize Engineered Cells and CRISPRevolution Kits in your research with new, affordable, and guaranteed solutions from Synthego. Join the Synthego team to learn about:
- How to design, edit, and analyze your CRISPR experiment
- Easy solutions to generate cell lines
- Fastest path to use CRISPR in your research
Space is limited. Lunch will be provided.
|
|
|
|
5 Weeks Away: 4th Annual Cancer Disparities Symposium
March 6, 2020
Tinkham Veale University Center, CWRU
The
4th Annual Cancer Disparities Symposium
: Cultivating Science and Community Engagement to Address Cancer Health Disparities is just 5 weeks away! Don't miss the opportunity to join researchers, physicians, and community leaders as we share cutting edge science and innovations in community engagement.
The
symposium agenda is now posted and features sessions on Cancer Disparities and Underserved Populations, such as sexual and gender minorities, Amish, and muslim women, Community Engagement and Support Programs, and Cancer Disparities Research and Community Engagement, plus invited presentations selected from standout abstract submissions. The final session of the day will be a multidisciplinary and thought-provoking panel discussion that will crystallize the energy and inspire us to continue toward the ultimate goal of health equity.
Robert T. Croyle, PhD of the National Cancer Institute will deliver the day's Plenary Address and and
Lucio Miele, MD, PhD from Louisiana State University is this year's Distinguished Scientific Keynote speaker.
Attendees are eligible to receive six (6) continuing research education credits (CRECs). Meals, materials, refreshments and parking will be provided.
|
|
|
|
|
Save The Date: Cancer Stem Cell Conference 2020
August 4-6, 2020
Tinkham Veale University Center
The Case Comprehensive Cancer Center and the National Center for Regenerative Medicine invite you to save the date for CSC 2020!
Now in its fourth year, CSC 2020 will feature renowned thought leaders in the field of cancer stem cell research. This conference is guaranteed to offer cutting-edge keynote presentations from a variety of niches within the field. Join world-class investigators for this three-day summit and network with scientists and clinicians advancing cancer stem cell research and therapeutic applications.
Registration will open in February.
|
|
|
|
Save The Date: Great Lakes Breast Cancer Symposium 2020
October 4-6, 2020
Tinkham Veale University Center, CWRU
As host site for the 2020 Great Lakes Breast Cancer Symposium, the Case Comprehensive Cancer Center encourages you to mark your calendar for the symposium taking place October 4-6, 2020.
The symposium highlights ongoing basic, translational, clinical and population studies addressing the biological mechanisms, management and prevention of breast cancer. Researchers from participating institutions will share their exciting work with a goal to develop cross-institutional collaborations.
This year's event features two keynote speakers:
- Carlos Arteaga, MD, Director of the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center
- Helen Piwnica-Worms, PhD, Professor of Experimental Radiation Oncology at the University of Texas MD Anderson Cancer Center
|
|
|
|
Additional Upcoming Events
|
|
|
Breast Cancer Update: Review of Breast Cancer Symposia
February 12, 2020 11:45a-4:15p
Embassy Suites, Independence
|
This review course will summarize highlights from the national breast cancer meetings, with a focus on the clinical implications of the new information presented at these meetings. Medical oncologists, breast surgeons, radiation oncologists, women’s health, nurses, nurse practitioners, physician assistants, residents and fellows and other health care providers with an interest in the management of patients with breast cancer should attend this course.
|
|
|
|
2020 Multidisciplinary Head and Neck Cancer Update
February 14-15, 2020
Fort Lauderdale, FL
|
This course will provide practicing physicians, residents, fellows, and nurses in medical oncology, otolaryngology, radiation oncology, and head and neck surgery with a contemporary update of management strategies of head and neck cancer using a multidisciplinary approach. Lecture and panels will provide a forum for discussion of updated therapies and new treatment innovations.
|
|
|
|
|
Management of Checkpoint Inhibitor-Related Toxicity Conference
March 6, 2020
InterContinental, Cleveland
|
Immune checkpoint blockade leads to a new spectrum of dysimmune toxicity requiring collaboration between oncologists, providers, and specialists to improve the understanding of the mechanism, diagnosis, and management of immune-related adverse events (irAEs). The goal of this conference is to bring together a multidisciplinary group of clinicians to share expertise and improve the care of patients receiving immune checkpoint inhibitor therapies.
|
|
|
|
NCCN 2020 Annual Conference
March 20-22, 2020
Orlando, FL
The National Comprehensive Cancer Network (NCCN) 2020 Annual Conference agenda includes 30 educational sessions featuring the latest advances in oncology care, including interactive patient case studies. Session topics include: HPV-Associated Cancers, Patient-Reported Outcomes, Clinical Trial Implementation, Value-Based Payment Models, Role of Biosimilars and more.
|
|
|
|
Deadline: March 16, 2020
The Damon Runyon Cancer Research Foundation is accepting proposals for both their Postdoctoral Fellowship Award and the Damon Runyon-Sohn Pediatric Fellowship Award.
The Postdoctoral Fellowship welcomes proposals in all theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention.
Together with the Sohn Conference Foundation, the Damon Runyon-Sohn Pediatric Cancer Fellowship Award provides funding to basic scientists and clinicians who conduct research with the potential to significantly impact the prevention, diagnosis or treatment of one or more pediatric cancers.
|
|
Deadline: April 1, 2020
The Cancer Research Institute (CRI) is currently accepting postdoctoral fellowship applications. The CRI Irvington Postdoctoral Fellowship Program furthers career development and supports laboratory research for promising young scientists working under the mentorship of leading immunologists. The award provides a total of $175,000 in support over three years.
CRI is seeking hypothesis-driven, mechanistic studies in both immunology and tumor immunology that aim to directly impact our understanding of the immune system’s role in cancer.
|
|
Radiology Business - Jan 28, 2020
“Myelin has never been directly imaged before. Our technique is the first to do so, and we are hopeful that this will provide earlier and more accurate diagnosis of MS,” said
Yanming Wang, PhD, co-inventor of the PET imaging agent and professor of radiology at Case Western Reserve University. Dr. Wang is a member of the
Case CCC's Cancer Imaging Program.
|
|
Cleveland.com - Jan 30, 2020
“Immunotherapy is the future of cancer care,” said
Theodoros Teknos, MD president and scientific director of the University Hospitals Seidman Cancer Center and deputy director of the
Case Comprehensive Cancer Center. "This is the hottest area of research," he said.
|
|
Weekly NIH Funding Opportunities and Notices
|
Notices
Funding Opportunities
First standard due date: May 25, 2020
First AIDS application due date: May 7, 2020.
|
|
Use the button below to submit all your news, events, announcements and communications requests to the Case CCC Marketing and Communications team!
|
|
|
|
|
|
|